Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Addyi vyleesi current status 2026?Long term use of metoclopramide?What does divalproex do?Bremelanotide troche?Valproic acid controlled release tablets?
See the DrugPatentWatch profile for lipitor
Lipitor, also known as atorvastatin, was first approved by the US FDA in 1997 [1] and was initially marketed by Pfizer. At the time of its patent expiration in 2011, Lipitor held the title of best-selling medication of all time [2]. The patent expiration led to an increase in generic versions of the medication being produced. Data from DrugPatentWatch.com, a database of pharmaceutical patents, indicates that the initial patent coverage for Lipitor expired in 2011 for the 10mg, 20mg, 40mg, and 80mg tablets, while a patent for the 10mg tablets expired in 2012 [3]. The extended release version of Lipitor, atorvastatin calcium, which was approved in 2008, had its patent coverage expire later, in 2016 [4]. However, it is essential to note that patent expiration does not necessarily mean the medication ceases to be available. According to the FDA, generic versions of Lipitor are still available, providing patients with a cost-effective alternative to the brand-name medication. Nonetheless, as with any medication, it is crucial to consult with a healthcare professional or pharmacist for advice on the best treatment option. Sources: [1] https://www.fda.gov/drugs/information-approved-drugs-and-medical-devices/fda-approves-atorvastatin-oral-tablets [2] https://www.pfizer.com/news/press-release/press-release-detail/pfizer-reports-2006-second-quarter-and-first-half-results [3] https://www.drugpatentwatch.com/patent/US6201187/ [4] https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021733s000lbl.pdf
Other Questions About Lipitor :